Additionally, Wang et al.29 compared mortality in a large cohort of patients with papillary thyroid cancer and found that males with BRAFV600E mutations had significantly higher mortality rates than females, but no difference in mortality rate was found between males and females in BRAF wild-type PTC. The gene discussed is BRAF; the disease is thyroid gland papillary carcinoma.